3653 results for «201»
3653 results
GulfPCR-GIM 2021 Opening Ceremony
15 Dec 2021 – From GulfPCR-GIM 2021
Listen to the enthusiastic speeches of the 4 Course Directors who are happy to open this 10th edition of the GulfPCR-GIM Congress and to present the main highlights of a program that promises to be dense and rich.
Ultra low contrast PCI in chronic kidney disease: what tools do we have? How to perform? How to achieve optimal outcome? How low can you go?
22 Dec 2021 – From GulfPCR-GIM 2021
Don't miss this session to understand how to perform ultra-low contrast PCI in complex disease and to discover SyncVision co-registration, Dynamic Coronary Roadmap, and the benefits for Azurion to perform ultra-low contrast PCI.
Mastering PCI in patients with complex lesions, ACS and HBR
22 Dec 2021 – From GulfPCR-GIM 2021
Watch this video if you wish to learn how to treat patients with complex anatomy, HBR feature, and presenting with ACS, to discuss the latest evidence about DAPT in HBR patients with acute coronary syndrome, and to ask open questions about DAPT for HBR patients.
Align to a line: improve clinical outcome of current and future patients with the Evolut platform
22 Dec 2021 – From GulfPCR-GIM 2021
Thanks to this session, aimed at revealing the exceptional performance of Evolut PRO+, learn key considerations for patients with longer life expectancy and explore the pathway to a single-digit pacemaker post-TAVI.
Pushing boundaries in tricuspid therapy - The TricValve solution
22 Dec 2021 – From GulfPCR-GIM 2021
In this session, learn about the TricValve system in the treatment of severe TR and right heart disease, obtain insight from the experts with case scenarios, and understand how the TricValve Transcatheter Bicavel system can help patients with severe TR.
Optimising TAVI results in patients with small aortic annuli
22 Dec 2021 – From GulfPCR-GIM 2021
This session will enable you to discuss the clinical outcomes of TAVI results in patients with small aortic annuli, learn how to best measure and assess gradients when performing TAVI, and review a case of a patient with small annuli treated with TAVI.
Complete revascularisation: from defining PCI strategy to PCI optimisation
22 Dec 2021 – From GulfPCR-GIM 2021
In this session on percutaneous coronary intervention, learn about available physiology tools for a full coronary assessment, understand how OCT impacts decision-making to strategise and optimise PCI, and learn through case examples how the use of physiology and OCT impacts daily practice.
Closing Ceremony
23 Nov 2021 – From PCR London Valves 2021
Looking back on some of the key moments of the PCR London Valves 2021, it is clear that we witnessed cutting-edge procedures in all three valves, pushed the guidelines to the limits and beyond, saw the future of valve procedures with a new TAVI device implanted, live-implanted...
STRIVE: intracoronary low-dose recombinant tissue plasminogen activator in primary PCI for STEMI and large thrombus burden
25 Oct 2025
Elad Asher provides his take on the STRIVE study presented by Shamir R. Mehta at TCT 2025, in San Francisco.

Author
Transcatheter aortic valve replacement in small aortic annuli: Results from the FRANCE-TAVI registry
17 Sep 2022
Mirvat Alasnag provides her take on the outcomes of small annuli sub-study from the FRANCE-TAVI Registry which included 1,195 patients. This trial was presented by Walid Ben-Ali at TCT 2022.

Author
Aortic stenosis and coronary artery disease: which should be treated first?
18 Jun 2026
In this review, Henryk Dreger explores the complex interplay between aortic stenosis and coronary artery disease, highlighting the latest evidence on PCI timing and its implications for clinical decision-making.

Author
DAPT-SHOCK-AMI trial: Cangrelor in cardiogenic shock
03 Sep 2025
Kalaivani Mahadevan and Fizzah Choudry provide their take on DAPT-SHOCK-MI presented by Zuzana Motovska at ESC Congress 2025 in Madrid.

Author

Author
Top Interventional Trials presented at ACC.21
07 Jun 2021
Ali Nazmi Calik provides a summary and key take-aways and infographics of 9 major trials of interest to interventional cardiologists presented at ACC.21

Author